{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:05:04Z","timestamp":1794366304899,"version":"4.9.0"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05540-2","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T04:32:33Z","timestamp":1753763553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?"],"prefix":"10.1186","volume":"29","author":[{"given":"Quentin","family":"Lajoye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Orieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Prevel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Jozwiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"5540_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13613-020-00760-x","volume":"10","author":"C Dupuis","year":"2020","unstructured":"Dupuis C, Bouadma L, Ruckly S, Perozziello A, Van-Gysel D, Mageau A, et al. Sepsis and septic shock in france: incidences, outcomes and costs of care. Ann Intensive Care. 2020;10:145.","journal-title":"Ann Intensive Care"},{"key":"5540_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/cc11511","volume":"16","author":"J-L Vincent","year":"2012","unstructured":"Vincent J-L. Increasing awareness of sepsis: world Sepsis day. Crit Care. 2012;16:152.","journal-title":"Crit Care"},{"key":"5540_CR3","first-page":"101082","volume":"41","author":"I Lakbar","year":"2022","unstructured":"Lakbar I, Munoz M, Pauly V, Orleans V, Fabre C, Fond G, et al. Septic shock: incidence, mortality and hospital readmission rates in French intensive care units from 2014 to 2018. Anaesth Crit Care Pain Med. 2022;41:101082.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"5540_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","volume":"23","author":"J-L Vincent","year":"2019","unstructured":"Vincent J-L, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North america: a systematic review and meta-analysis. Crit Care Lond Engl. 2019;23:196.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"5540_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","volume":"44","author":"C Martin","year":"2015","unstructured":"Martin C, Medam S, Antonini F, Alingrin J, Haddam M, Hammad E, et al. Norepinephrine: not too much, too long. Shock Augusta Ga. 2015;44:305\u20139.","journal-title":"Shock Augusta Ga"},{"key":"5540_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00000539-200107000-00003","volume":"93","author":"MW D\u00fcnser","year":"2001","unstructured":"D\u00fcnser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg. 2001;93:7\u201313.","journal-title":"Anesth Analg"},{"key":"5540_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/0885066609340519","volume":"24","author":"MW D\u00fcnser","year":"2009","unstructured":"D\u00fcnser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009;24:293\u2013316.","journal-title":"J Intensive Care Med"},{"key":"5540_CR9","doi-asserted-by":"publisher","first-page":"e237643","DOI":"10.1136\/bcr-2020-237643","volume":"13","author":"J Hansel","year":"2020","unstructured":"Hansel J, \u00c1rmannsson GS. Cardiac arrest due to accidental overdose with norepinephrine dissolved in crystalloid. BMJ Case Rep. 2020;13:e237643.","journal-title":"BMJ Case Rep"},{"key":"5540_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1582-4934.2007.00009.x","volume":"11","author":"M Neri","year":"2007","unstructured":"Neri M, Cerretani D, Fiaschi AI, Laghi PF, Lazzerini PE, Maffione AB, et al. Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats. J Cell Mol Med. 2007;11:156\u201370.","journal-title":"J Cell Mol Med"},{"key":"5540_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1164\/rccm.201604-0862CP","volume":"194","author":"RF Stolk","year":"2016","unstructured":"Stolk RF, van der Poll T, Angus DC, van der Hoeven JG, Pickkers P, Kox M. Potentially inadvertent immunomodulation: norepinephrine use in Sepsis. Am J Respir Crit Care Med. 2016;194:550\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"5540_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0140-6736(03)12231-3","volume":"361","author":"M Lyte","year":"2003","unstructured":"Lyte M, Freestone PPE, Neal CP, Olson BA, Haigh RD, Bayston R, et al. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine Inotropes. Lancet Lond Engl. 2003;361:130\u20135.","journal-title":"Lancet Lond Engl"},{"key":"5540_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13613-019-0498-7","volume":"9","author":"TWL Scheeren","year":"2019","unstructured":"Scheeren TWL, Bakker J, De Backer D, Annane D, Asfar P, Boerma EC, et al. Current use of vasopressors in septic shock. Ann Intensive Care. 2019;9:20.","journal-title":"Ann Intensive Care"},{"key":"5540_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jcrc.2021.11.016","volume":"68","author":"E Bitton","year":"2022","unstructured":"Bitton E, Zimmerman S, Azevedo LCP, Benhamou D, Cecconi M, De Waele JJ, et al. An international survey of adherence to surviving Sepsis campaign guidelines 2016 regarding fluid resuscitation and vasopressors in the initial management of septic shock. J Crit Care. 2022;68:144\u201354.","journal-title":"J Crit Care"},{"key":"5540_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jcrc.2018.12.007","volume":"50","author":"MK Abril","year":"2019","unstructured":"Abril MK, Khanna AK, Kroll S, McNamara C, Handisides D, Busse LW. Regional differences in the treatment of refractory vasodilatory shock using angiotensin II in high output shock (ATHOS-3) data. J Crit Care. 2019;50:188\u201394.","journal-title":"J Crit Care"},{"key":"5540_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/CCM.0000000000005305","volume":"50","author":"GL Sacha","year":"2022","unstructured":"Sacha GL, Kiser TH, Wright GC, Vandivier RW, Moss M, Burnham EL, et al. Association between vasopressin rebranding and utilization in patients with septic shock. Crit Care Med. 2022;50:644\u201354.","journal-title":"Crit Care Med"},{"key":"5540_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ccc.2018.11.004","volume":"35","author":"I-F Ukor","year":"2019","unstructured":"Ukor I-F, Walley KR. Vasopressin in vasodilatory shock. Crit Care Clin. 2019;35:247\u201361.","journal-title":"Crit Care Clin"},{"key":"5540_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13613-020-0628-2","volume":"10","author":"J Demiselle","year":"2020","unstructured":"Demiselle J, Fage N, Radermacher P, Asfar P. Vasopressin and its analogues in shock states: a review. Ann Intensive Care. 2020;10:9.","journal-title":"Ann Intensive Care"},{"key":"5540_CR19","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.3390\/jcm12144589","volume":"12","author":"O Hamzaoui","year":"2023","unstructured":"Hamzaoui O, Goury A, Teboul J-L. The eight unanswered and answered questions about the use of vasopressors in septic shock. J Clin Med. 2023;12:4589.","journal-title":"J Clin Med"},{"key":"5540_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.21037\/atm.2020.04.24","volume":"8","author":"R Shi","year":"2020","unstructured":"Shi R, Hamzaoui O, De Vita N, Monnet X, Teboul J-L. Vasopressors in septic shock: which, when, and how much? Ann Transl Med. 2020;8:794.","journal-title":"Ann Transl Med"},{"key":"5540_CR21","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3390\/jpm13111548","volume":"13","author":"R Garc\u00eda-\u00c1lvarez","year":"2023","unstructured":"Garc\u00eda-\u00c1lvarez R, Arboleda-Salazar R. Vasopressin in Sepsis and other shock states: state of the Art. J Pers Med. 2023;13:1548.","journal-title":"J Pers Med"},{"key":"5540_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D De Backer","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779\u201389.","journal-title":"N Engl J Med"},{"key":"5540_CR23","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/ALN.0b013e31824f9669","volume":"116","author":"N Ducrocq","year":"2012","unstructured":"Ducrocq N, Kimmoun A, Furmaniuk A, Hekalo Z, Maskali F, Poussier S, et al. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction. Anesthesiology. 2012;116:1083\u201391.","journal-title":"Anesthesiology"},{"key":"5540_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00134-024-07374-y","volume":"50","author":"E Kattan","year":"2024","unstructured":"Kattan E, Ibarra-Estrada M, Jung C. Knowing the ropes of vasopressor dosing: a focus on norepinephrine. Intensive Care Med. 2024;50:587\u20139.","journal-title":"Intensive Care Med"},{"key":"5540_CR25","doi-asserted-by":"publisher","first-page":"R142","DOI":"10.1186\/cc9207","volume":"14","author":"O Hamzaoui","year":"2010","unstructured":"Hamzaoui O, Georger J-F, Monnet X, Ksouri H, Maizel J, Richard C, et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care Lond Engl. 2010;14:R142.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/CCM.0b013e318206d2a3","volume":"39","author":"X Monnet","year":"2011","unstructured":"Monnet X, Jabot J, Maizel J, Richard C, Teboul J-L. Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg Raising in septic shock patients. Crit Care Med. 2011;39:689\u201394.","journal-title":"Crit Care Med"},{"key":"5540_CR27","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1097\/CCM.0b013e318260c6c3","volume":"40","author":"R Persichini","year":"2012","unstructured":"Persichini R, Silva S, Teboul J-L, Jozwiak M, Chemla D, Richard C, et al. Effects of norepinephrine on mean systemic pressure and venous return in human septic shock. Crit Care Med. 2012;40:3146\u201353.","journal-title":"Crit Care Med"},{"key":"5540_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13054-021-03711-5","volume":"25","author":"I Adda","year":"2021","unstructured":"Adda I, Lai C, Teboul J-L, Guerin L, Gavelli F, Monnet X. Norepinephrine potentiates the efficacy of volume expansion on mean systemic pressure in septic shock. Crit Care Lond Engl. 2021;25:302.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000158924","volume":"29","author":"J Quillen","year":"2008","unstructured":"Quillen J, Sellke F, Banitt P, Harrison D. The effect of norepinephrine on the coronary microcirculation. J Vasc Res. 2008;29:2\u20137.","journal-title":"J Vasc Res"},{"key":"5540_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bja.2017.11.065","volume":"120","author":"O Hamzaoui","year":"2018","unstructured":"Hamzaoui O, Jozwiak M, Geffriaud T, Sztrymf B, Prat D, Jacobs F, et al. Norepinephrine exerts an inotropic effect during the early phase of human septic shock. Br J Anaesth. 2018;120:517\u201324.","journal-title":"Br J Anaesth"},{"key":"5540_CR31","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/cc7922","volume":"13","author":"A Dubin","year":"2009","unstructured":"Dubin A, Pozo MO, Casabella CA, P\u00e1lizas F, Murias G, Moseinco MC, et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care Lond Engl. 2009;13:R92.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR32","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1097\/CCM.0b013e3181a00a1c","volume":"37","author":"S Jhanji","year":"2009","unstructured":"Jhanji S, Stirling S, Patel N, Hinds CJ, Pearse RM. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med. 2009;37:1961\u20136.","journal-title":"Crit Care Med"},{"key":"5540_CR33","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1007\/s00134-010-2013-3","volume":"36","author":"J-F Georger","year":"2010","unstructured":"Georger J-F, Hamzaoui O, Chaari A, Maizel J, Richard C, Teboul J-L. Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med. 2010;36:1882\u20139.","journal-title":"Intensive Care Med"},{"key":"5540_CR34","doi-asserted-by":"crossref","unstructured":"van Diepen S. Norepinephrine as a First-Line inopressor in cardiogenic shock. J Am Coll Cardiol. 2018;72:183\u20136.","DOI":"10.1016\/j.jacc.2018.04.052"},{"key":"5540_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","volume":"7","author":"T Auchet","year":"2017","unstructured":"Auchet T, Regnier M-A, Girerd N, Levy B. Outcome of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care. 2017;7:43.","journal-title":"Ann Intensive Care"},{"key":"5540_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.chest.2022.07.018","volume":"163","author":"R Sato","year":"2023","unstructured":"Sato R, Duggal A, Sacha GL, Rudoni MA, Yataco AC, Khanna AK, et al. The relationship between norepinephrine equivalent dose of vasopressors within 24 hours from the onset of septic shock and In-Hospital mortality rate. Chest. 2023;163:148\u201351.","journal-title":"Chest"},{"key":"5540_CR37","doi-asserted-by":"publisher","first-page":"R181","DOI":"10.1186\/cc8167","volume":"13","author":"MW D\u00fcnser","year":"2009","unstructured":"D\u00fcnser MW, Ruokonen E, Pettil\u00e4 V, Ulmer H, Torgersen C, Schmittinger CA, et al. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care. 2009;13:R181.","journal-title":"Crit Care"},{"key":"5540_CR38","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.CCM.0000048621.36569.69","volume":"31","author":"M Bucher","year":"2003","unstructured":"Bucher M, Kees F, Taeger K, Kurtz A. Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med. 2003;31:566\u201371.","journal-title":"Crit Care Med"},{"key":"5540_CR39","doi-asserted-by":"publisher","first-page":"e225879","DOI":"10.1136\/bcr-2018-225879","volume":"12","author":"WM Mampuya","year":"2019","unstructured":"Mampuya WM, Dumont J, Lamontagne F. Norepinephrine-associated left ventricular outflow tract obstruction and systolic anterior movement. BMJ Case Rep. 2019;12:e225879.","journal-title":"BMJ Case Rep"},{"key":"5540_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/SHK.0b013e318289376b","volume":"39","author":"CA Schmittinger","year":"2013","unstructured":"Schmittinger CA, D\u00fcnser MW, Torgersen C, Luckner G, Lorenz I, Schmid S, et al. Histologic pathologies of the myocardium in septic shock: a prospective observational study. Shock Augusta Ga. 2013;39:329\u201335.","journal-title":"Shock Augusta Ga"},{"key":"5540_CR41","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1164\/rccm.202002-0339OC","volume":"202","author":"RF Stolk","year":"2020","unstructured":"Stolk RF, van der Pasch E, Naumann F, Schouwstra J, Bressers S, van Herwaarden AE, et al. Norepinephrine dysregulates the immune response and compromises host defense during Sepsis. Am J Respir Crit Care Med. 2020;202:830\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"5540_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s13054-023-04739-5","volume":"27","author":"B Garcia","year":"2023","unstructured":"Garcia B, Zarbock A, Bellomo R, Legrand M. The alternative renin-angiotensin system in critically ill patients: pathophysiology and therapeutic implications. Crit Care Lond Engl. 2023;27:453.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR43","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","volume":"45","author":"JA Russell","year":"2019","unstructured":"Russell JA. Vasopressor therapy in critically ill patients with shock. Intensive Care Med. 2019;45:1503\u201317.","journal-title":"Intensive Care Med"},{"key":"5540_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13613-018-0449-8","volume":"8","author":"O Lesur","year":"2018","unstructured":"Lesur O, Delile E, Asfar P, Radermacher P. Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questions. Ann Intensive Care. 2018;8:102.","journal-title":"Ann Intensive Care"},{"key":"5540_CR45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1750-3639.2009.00355.x","volume":"20","author":"R Sonneville","year":"2009","unstructured":"Sonneville R, Guidoux C, Barrett L, Viltart O, Mattot V, Polito A, et al. Vasopressin synthesis by the magnocellular neurons is different in the supraoptic nucleus and in the paraventricular nucleus in human and experimental septic shock. Brain Pathol. 2009;20:613\u201322.","journal-title":"Brain Pathol"},{"key":"5540_CR46","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1024\/0040-5930.66.11.731","volume":"66","author":"J Rutishauser","year":"2009","unstructured":"Rutishauser J. [Copeptin: diagnostic parameter, biomarker, or both?]. Ther Umsch Rev Ther. 2009;66:731\u20134.","journal-title":"Ther Umsch Rev Ther"},{"key":"5540_CR47","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/00000542-200609000-00026","volume":"105","author":"TA Treschan","year":"2006","unstructured":"Treschan TA, Peters J. The vasopressin system: physiology and clinical strategies. Anesthesiology. 2006;105:599\u2013612. quiz 639\u201340.","journal-title":"Anesthesiology"},{"key":"5540_CR48","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1601-183X.2006.00281.x","volume":"6","author":"SR Wersinger","year":"2007","unstructured":"Wersinger SR, Caldwell HK, Martinez L, Gold P, Hu S-B, Young WS. Vasopressin 1a receptor knockout mice have a subtle olfactory deficit but normal aggression. Genes Brain Behav. 2007;6:540\u201351.","journal-title":"Genes Brain Behav"},{"key":"5540_CR49","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/S0021-9258(18)69117-3","volume":"263","author":"LR Grillone","year":"1988","unstructured":"Grillone LR, Clark MA, Godfrey RW, Stassen F, Crooke ST. Vasopressin induces V1 receptors to activate phosphatidylinositol- and phosphatidylcholine-specific phospholipase C and stimulates the release of arachidonic acid by at least two pathways in the smooth muscle cell line, A-10. J Biol Chem. 1988;263:2658\u201363.","journal-title":"J Biol Chem"},{"key":"5540_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0024-3205(86)90435-2","volume":"39","author":"N Aiyar","year":"1986","unstructured":"Aiyar N, Nambi P, Stassen FL, Crooke ST. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line. Life Sci. 1986;39:37\u201345.","journal-title":"Life Sci"},{"key":"5540_CR51","first-page":"H1228","volume":"257","author":"AW Wallace","year":"1989","unstructured":"Wallace AW, Tunin CM, Shoukas AA. Effects of vasopressin on pulmonary and systemic vascular mechanics. Am J Physiol. 1989;257:H1228\u20131234.","journal-title":"Am J Physiol"},{"key":"5540_CR52","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1378\/chest.103.4.1241","volume":"103","author":"PR Evora","year":"1993","unstructured":"Evora PR, Pearson PJ, Schaff HV. Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest. 1993;103:1241\u20135.","journal-title":"Chest"},{"key":"5540_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.CCM.0000251127.45385.CD","volume":"35","author":"LK Barrett","year":"2007","unstructured":"Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35:33\u201340.","journal-title":"Crit Care Med"},{"key":"5540_CR54","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","volume":"31","author":"T Sharshar","year":"2003","unstructured":"Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med. 2003;31:1752\u20138.","journal-title":"Crit Care Med"},{"key":"5540_CR55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jointm.2022.05.001","volume":"2","author":"M Jozwiak","year":"2022","unstructured":"Jozwiak M. Alternatives to norepinephrine in septic shock: which agents and when? J Intensive Med. 2022;2:223\u201332.","journal-title":"J Intensive Med"},{"key":"5540_CR56","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.yhbeh.2004.07.004","volume":"46","author":"SR Wersinger","year":"2004","unstructured":"Wersinger SR, Kelliher KR, Zufall F, Lolait SJ, O\u2019Carroll A-M, Young WS. Social motivation is reduced in vasopressin 1b receptor null mice despite normal performance in an olfactory discrimination task. Horm Behav. 2004;46:638\u201345.","journal-title":"Horm Behav"},{"key":"5540_CR57","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00726-011-1109-6","volume":"43","author":"A Kwiatkowska","year":"2012","unstructured":"Kwiatkowska A, Ptach M, Borovi\u010dkov\u00e1 L, Slaninov\u00e1 J, Lammek B, Prahl A. Design, synthesis and biological activity of new neurohypophyseal hormones analogues conformationally restricted in the N-terminal part of the molecule. Highly potent OT receptor antagonists. Amino Acids. 2012;43:617\u201327.","journal-title":"Amino Acids"},{"key":"5540_CR58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ng1092-103","volume":"2","author":"Y Pan","year":"1992","unstructured":"Pan Y, Metzenberg A, Das S, Jing B, Gitschier J. Mutations in the V2 vasopressin receptor gene are associated with X\u2013linked nephrogenic diabetes insipidus. Nat Genet. 1992;2:103\u20136.","journal-title":"Nat Genet"},{"key":"5540_CR59","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1182\/blood.V86.7.2760.2760","volume":"86","author":"S Kanwar","year":"1995","unstructured":"Kanwar S, Woodman RC, Poon MC, Murohara T, Lefer AM, Davenpeck KL, et al. Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules. Blood. 1995;86:2760\u20136.","journal-title":"Blood"},{"key":"5540_CR60","doi-asserted-by":"publisher","unstructured":"Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock.| New England Journal of Medicine [Internet]. [cited 2024 Jul 26]. Available from: https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/NEJMoa067373","DOI":"10.1056\/NEJMoa067373"},{"key":"5540_CR61","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509\u201318.","journal-title":"JAMA"},{"key":"5540_CR62","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/CCM.0000000000004023","volume":"47","author":"LA Hajjar","year":"2019","unstructured":"Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G, et al. Vasopressin versus norepinephrine for the management of septic shock in Cancer patients: the VANCS II randomized clinical trial. Crit Care Med. 2019;47:1743\u201350.","journal-title":"Crit Care Med"},{"key":"5540_CR63","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","volume":"45","author":"M Nagendran","year":"2019","unstructured":"Nagendran M, Russell JA, Walley KR, Brett SJ, Perkins GD, Hajjar L, et al. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med. 2019;45:844\u201355.","journal-title":"Intensive Care Med"},{"key":"5540_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ajem.2021.05.007","volume":"48","author":"H Huang","year":"2021","unstructured":"Huang H, Wu C, Shen Q, Xu H, Fang Y, Mao W. The effect of early vasopressin use on patients with septic shock: A systematic review and meta-analysis. Am J Emerg Med. 2021;48:203\u20138.","journal-title":"Am J Emerg Med"},{"key":"5540_CR65","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.4528","volume":"319","author":"WF McIntyre","year":"2018","unstructured":"McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, et al. Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: A systematic review and Meta-analysis. JAMA. 2018;319:1889\u2013900.","journal-title":"JAMA"},{"key":"5540_CR66","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-019-2362-4","volume":"23","author":"L Jiang","year":"2019","unstructured":"Jiang L, Sheng Y, Feng X, Wu J. The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis. Crit Care Lond Engl. 2019;23:91.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR67","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","volume":"32","author":"F Lauzier","year":"2006","unstructured":"Lauzier F, L\u00e9vy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med. 2006;32:1782\u20139.","journal-title":"Intensive Care Med"},{"key":"5540_CR68","first-page":"273","volume":"17","author":"DJ Brackett","year":"1985","unstructured":"Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, Wilson MF. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock. 1985;17:273\u201384.","journal-title":"Circ Shock"},{"key":"5540_CR69","doi-asserted-by":"crossref","unstructured":"Bakker J, Kattan E, Annane D, Castro R, Cecconi M, De Backer D et al. Current practice and evolving concepts in septic shock resuscitation. Intensive Care Med. 2021;48.","DOI":"10.1007\/s00134-021-06595-9"},{"key":"5540_CR70","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","volume":"95","author":"DW Landry","year":"1997","unstructured":"Landry DW, Levin HR, Gallant EM, Ashton RC, Seo S, D\u2019Alessandro D, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122\u20135.","journal-title":"Circulation"},{"key":"5540_CR71","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1164\/ajrccm.160.2.9810073","volume":"160","author":"D Annane","year":"1999","unstructured":"Annane D, Trabold F, Sharshar T, Jarrin I, Blanc AS, Raphael JC, et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med. 1999;160:458\u201365.","journal-title":"Am J Respir Crit Care Med"},{"key":"5540_CR72","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF01819137","volume":"3","author":"CS Garrard","year":"1993","unstructured":"Garrard CS, Kontoyannis DA, Piepoli M. Spectral analysis of heart rate variability in the sepsis syndrome. Clin Auton Res Off J Clin Auton Res Soc. 1993;3:5\u201313.","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"key":"5540_CR73","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1097\/CCM.0b013e3181eb9acf","volume":"38","author":"S Siami","year":"2010","unstructured":"Siami S, Bailly-Salin J, Polito A, Porcher R, Blanchard A, Haymann J-P, et al. Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock. Crit Care Med. 2010;38:1962\u20139.","journal-title":"Crit Care Med"},{"key":"5540_CR74","first-page":"77","volume":"286","author":"JA Spitzer","year":"1989","unstructured":"Spitzer JA, Rodriguez de Turco EB. Modification of adrenergic and vasopressin receptor-linked lipid metabolism during endotoxemia. Prog Clin Biol Res. 1989;286:77\u201399.","journal-title":"Prog Clin Biol Res"},{"key":"5540_CR75","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00003246-200203000-00001","volume":"30","author":"T Sharshar","year":"2002","unstructured":"Sharshar T, Carlier R, Blanchard A, Feydy A, Gray F, Paillard M, et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med. 2002;30:497\u2013500.","journal-title":"Crit Care Med"},{"key":"5540_CR76","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(03)14899-4","volume":"362","author":"T Sharshar","year":"2003","unstructured":"Sharshar T, Gray F, de la Lorin G, Hopkinson NS, Ross E, Dorandeu A, et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet Lond Engl. 2003;362:1799\u2013805.","journal-title":"Lancet Lond Engl"},{"key":"5540_CR77","first-page":"15","volume":"6","author":"MF Wilson","year":"1981","unstructured":"Wilson MF, Brackett DJ, Tompkins P, Benjamin B, Archer LT, Hinshaw LB. Elevated plasma vasopressin concentrations during endotoxin and E. coli shock. Adv Shock Res. 1981;6:15\u201326.","journal-title":"Adv Shock Res"},{"key":"5540_CR78","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1007\/s12035-016-0094-x","volume":"54","author":"LHA da Costa","year":"2017","unstructured":"da Costa LHA, J\u00fanior NNDS, Catal\u00e3o CHR, Sharshar T, Chr\u00e9tien F, da Rocha MJA. Vasopressin impairment during Sepsis is associated with hypothalamic intrinsic apoptotic pathway and microglial activation. Mol Neurobiol. 2017;54:5526\u201333.","journal-title":"Mol Neurobiol"},{"key":"5540_CR79","doi-asserted-by":"publisher","first-page":"R979","DOI":"10.1152\/ajpregu.00520.2001","volume":"282","author":"M Bucher","year":"2002","unstructured":"Bucher M, Hobbhahn J, Taeger K, Kurtz A. Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol. 2002;282:R979\u2013984.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5540_CR80","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","volume":"107","author":"MW D\u00fcnser","year":"2003","unstructured":"D\u00fcnser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313\u20139.","journal-title":"Circulation"},{"key":"5540_CR81","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","volume":"96","author":"BM Patel","year":"2002","unstructured":"Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002;96:576\u201382.","journal-title":"Anesthesiology"},{"key":"5540_CR82","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","volume":"47","author":"MB Malay","year":"1999","unstructured":"Malay MB, Ashton RC, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47:699\u2013703. discussion 703\u2013705.","journal-title":"J Trauma"},{"key":"5540_CR83","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/00003246-200103000-00004","volume":"29","author":"I Tsuneyoshi","year":"2001","unstructured":"Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med. 2001;29:487\u201393.","journal-title":"Crit Care Med"},{"key":"5540_CR84","doi-asserted-by":"publisher","first-page":"R217","DOI":"10.1186\/cc10453","volume":"15","author":"A Morelli","year":"2011","unstructured":"Morelli A, Donati A, Ertmer C, Rehberg S, Kampmeier T, Orecchioni A, et al. Effects of vasopressinergic receptor agonists on Sublingual microcirculation in norepinephrine-dependent septic shock. Crit Care. 2011;15:R217.","journal-title":"Crit Care"},{"key":"5540_CR85","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0741-5214(85)90099-0","volume":"2","author":"JC Kerr","year":"1985","unstructured":"Kerr JC, Jain KM, Swan KG, Rocko JM. Effects of vasopressin on cardiac output and its distribution in the subhuman primate. J Vasc Surg. 1985;2:443\u20139.","journal-title":"J Vasc Surg"},{"key":"5540_CR86","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1476-5381.1986.tb10204.x","volume":"87","author":"RP Hof","year":"1986","unstructured":"Hof RP. Vasopressin induced myocardial depression in neurally mediated and not due to impaired coronary blood flow. Br J Pharmacol. 1986;87:611\u20138.","journal-title":"Br J Pharmacol"},{"key":"5540_CR87","first-page":"273","volume":"156","author":"O-J How","year":"2010","unstructured":"How O-J, R\u00f8sner A, Kildal AB, Stenberg TA, Gjessing PF, Hermansen SE, et al. Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock. Transl Res J Lab Clin Med. 2010;156:273\u201381.","journal-title":"Transl Res J Lab Clin Med"},{"key":"5540_CR88","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1378\/chest.11-2604","volume":"142","author":"AC Gordon","year":"2012","unstructured":"Gordon AC, Wang N, Walley KR, Ashby D, Russell JA. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock. Chest. 2012;142:593\u2013605.","journal-title":"Chest"},{"key":"5540_CR89","doi-asserted-by":"publisher","first-page":"154298","DOI":"10.1016\/j.jcrc.2023.154298","volume":"76","author":"S Dugar","year":"2023","unstructured":"Dugar S, Siuba MT, Sacha GL, Sato R, Moghekar A, Collier P, et al. Echocardiographic profiles and hemodynamic response after vasopressin initiation in septic shock: A cross-sectional study. J Crit Care. 2023;76:154298.","journal-title":"J Crit Care"},{"key":"5540_CR90","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s00134-022-06708-y","volume":"48","author":"M Legrand","year":"2022","unstructured":"Legrand M, Zarbock A. Ten tips to optimize vasopressors use in the critically ill patient with hypotension. Intensive Care Med. 2022;48:736\u20139.","journal-title":"Intensive Care Med"},{"key":"5540_CR91","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","volume":"126","author":"LA Hajjar","year":"2017","unstructured":"Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, Rhodes A, Landoni G, Osawa EA, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial. Anesthesiology. 2017;126:85\u201393.","journal-title":"Anesthesiology"},{"key":"5540_CR92","doi-asserted-by":"publisher","first-page":"R117","DOI":"10.1186\/cc12789","volume":"17","author":"S Mehta","year":"2013","unstructured":"Mehta S, Granton J, Gordon AC, Cook DJ, Lapinsky S, Newton G, et al. Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine. Crit Care. 2013;17:R117.","journal-title":"Crit Care"},{"key":"5540_CR93","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(20)30733-9","volume":"396","author":"N Br\u00e9chot","year":"2020","unstructured":"Br\u00e9chot N, Hajage D, Kimmoun A, Demiselle J, Agerstrand C, Montero S, et al. Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study. Lancet Lond Engl. 2020;396:545\u201352.","journal-title":"Lancet Lond Engl"},{"key":"5540_CR94","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/cc7959","volume":"13","author":"F Simon","year":"2009","unstructured":"Simon F, Giudici R, Scheuerle A, Gr\u00f6ger M, Asfar P, Vogt JA, et al. Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during Porcine fecal peritonitis: a randomized controlled trial. Crit Care Lond Engl. 2009;13:R113.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR95","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13054-022-04161-3","volume":"26","author":"B Garcia","year":"2022","unstructured":"Garcia B, Su F, Dewachter L, Favory R, Khaldi A, Moiroux-Sahraoui A, et al. Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock. Crit Care Lond Engl. 2022;26:281.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR96","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/SHK.0000000000002109","volume":"59","author":"EJ See","year":"2023","unstructured":"See EJ, Clapham C, Liu J, Khasin M, Liskaser G, Chan JW, et al. A PILOT STUDY OF ANGIOTENSIN II AS PRIMARY VASOPRESSOR IN CRITICALLY ILL ADULTS WITH VASODILATORY HYPOTENSION: THE ARAMIS STUDY. Shock Augusta Ga. 2023;59:691\u20136.","journal-title":"Shock Augusta Ga"},{"key":"5540_CR97","first-page":"F274","volume":"256","author":"RM Edwards","year":"1989","unstructured":"Edwards RM, Trizna W, Kinter LB. Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol. 1989;256:F274\u2013278.","journal-title":"Am J Physiol"},{"key":"5540_CR98","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ki.1996.101","volume":"49","author":"T Tamaki","year":"1996","unstructured":"Tamaki T, Kiyomoto K, He H, Tomohiro A, Nishiyama A, Aki Y, et al. Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles. Kidney Int. 1996;49:722\u20139.","journal-title":"Kidney Int"},{"key":"5540_CR99","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","volume":"36","author":"AC Gordon","year":"2010","unstructured":"Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM, et al. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med. 2010;36:83\u201391.","journal-title":"Intensive Care Med"},{"key":"5540_CR100","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1164\/rccm.200109-016OC","volume":"166","author":"D De Backer","year":"2002","unstructured":"De Backer D, Creteur J, Preiser J-C, Dubois M-J, Vincent J-L. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166:98\u2013104.","journal-title":"Am J Respir Crit Care Med"},{"key":"5540_CR101","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jss.2018.10.028","volume":"235","author":"H Bomberg","year":"2019","unstructured":"Bomberg H, Bierbach B, Flache S, Nov\u00e1k M, Sch\u00e4fers H-J, Menger MD. Dobutamine versus vasopressin after mesenteric ischemia. J Surg Res. 2019;235:410\u201323.","journal-title":"J Surg Res"},{"key":"5540_CR102","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.athoracsur.2016.03.025","volume":"102","author":"H Bomberg","year":"2016","unstructured":"Bomberg H, Groesdonk HV, Raffel M, Minko P, Schmied W, Klingele M, et al. Vasopressin as therapy during nonocclusive mesenteric ischemia. Ann Thorac Surg. 2016;102:813\u20139.","journal-title":"Ann Thorac Surg"},{"key":"5540_CR103","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0022-4804(76)90146-3","volume":"20","author":"SE Wilson","year":"1976","unstructured":"Wilson SE, Fisher SL, Hiatt JR, Winston MA. Effect of vasopressin on mesenteric blood flow determined by the clearance of radioxenon. J Surg Res. 1976;20:237\u201342.","journal-title":"J Surg Res"},{"key":"5540_CR104","doi-asserted-by":"publisher","first-page":"826446","DOI":"10.3389\/fmed.2022.826446","volume":"9","author":"M Jozwiak","year":"2022","unstructured":"Jozwiak M, Geri G, Laghlam D, Boussion K, Dolladille C, Nguyen LS. Vasopressors and risk of acute mesenteric ischemia: A worldwide pharmacovigilance analysis and comprehensive literature review. Front Med. 2022;9:826446.","journal-title":"Front Med"},{"key":"5540_CR105","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jocs.12242","volume":"29","author":"H Bomberg","year":"2014","unstructured":"Bomberg H, Bierbach B, Flache S, Scheuer C, Nov\u00e1k M, Sch\u00e4fers H-J, et al. Vasopressin induces rectosigmoidal mucosal ischemia during cardiopulmonary bypass. J Card Surg. 2014;29:108\u201315.","journal-title":"J Card Surg"},{"key":"5540_CR106","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1097\/01.CCM.0000094260.05266.F4","volume":"31","author":"S Klinzing","year":"2003","unstructured":"Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med. 2003;31:2646\u201350.","journal-title":"Crit Care Med"},{"key":"5540_CR107","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/08850666221118282","volume":"38","author":"SR Bauer","year":"2023","unstructured":"Bauer SR, Sacha GL, Siuba MT, Wang L, Wang X, Scheraga RG, et al. Vasopressin response and clinical trajectory in septic shock patients. J Intensive Care Med. 2023;38:273\u20139.","journal-title":"J Intensive Care Med"},{"key":"5540_CR108","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/phar.2683","volume":"42","author":"A Scheibner","year":"2022","unstructured":"Scheibner A, Betthauser KD, Bewley AF, Juang P, Lizza B, Micek S, et al. Machine learning to predict vasopressin responsiveness in patients with septic shock. Pharmacotherapy. 2022;42:460\u201371.","journal-title":"Pharmacotherapy"},{"key":"5540_CR109","doi-asserted-by":"publisher","first-page":"170437","DOI":"10.1016\/j.peptides.2020.170437","volume":"136","author":"DA Gomes","year":"2021","unstructured":"Gomes DA, de Almeida Beltr\u00e3o RL, de Oliveira Junior FM, da Silva Junior JC, de Arruda EPC, Lira EC, et al. Vasopressin and copeptin release during sepsis and septic shock. Peptides. 2021;136:170437.","journal-title":"Peptides"},{"key":"5540_CR110","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11154-019-09509-9","volume":"20","author":"M Christ-Crain","year":"2019","unstructured":"Christ-Crain M. Vasopressin and copeptin in health and disease. Rev Endocr Metab Disord. 2019;20:283\u201394.","journal-title":"Rev Endocr Metab Disord"},{"key":"5540_CR111","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1056\/NEJMoa2306263","volume":"389","author":"J Refardt","year":"2023","unstructured":"Refardt J, Atila C, Chifu I, Ferrante E, Erlic Z, Drummond JB, et al. Arginine or hypertonic Saline-Stimulated copeptin to diagnose AVP deficiency. N Engl J Med. 2023;389:1877\u201387.","journal-title":"N Engl J Med"},{"key":"5540_CR112","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s00134-017-4909-7","volume":"44","author":"J-L Teboul","year":"2018","unstructured":"Teboul J-L, Duranteau J, Russell JA. Intensive care medicine in 2050: vasopressors in sepsis. Intensive Care Med. 2018;44:1130\u20132.","journal-title":"Intensive Care Med"},{"key":"5540_CR113","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00134-024-07332-8","volume":"50","author":"D De Backer","year":"2024","unstructured":"De Backer D, Hajjar L, Monnet X. Vasoconstriction in septic shock. Intensive Care Med. 2024;50:459\u201362.","journal-title":"Intensive Care Med"},{"key":"5540_CR114","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00134-022-06652-x","volume":"48","author":"M Leone","year":"2022","unstructured":"Leone M, Goyer I, Levy B, D\u00fcnser MW, Asfar P, Jentzer JC. Dose of norepinephrine: the devil is in the details. Intensive Care Med. 2022;48:638\u201340.","journal-title":"Intensive Care Med"},{"key":"5540_CR115","doi-asserted-by":"crossref","unstructured":"Wieruszewski P, Leone M, Kaas-Hansen B, Dugar S, Legrand M, McKenzie C et al. Position paper on the reporting of norepinephrine formulations in critical care from the society of critical care medicine and European society of intensive care medicine joint task force. Crit Care Med. 2024;52.","DOI":"10.1097\/CCM.0000000000006176"},{"key":"5540_CR116","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12879-023-08147-6","volume":"23","author":"J Xu","year":"2023","unstructured":"Xu J, Cai H, Zheng X. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases. BMC Infect Dis. 2023;23:199.","journal-title":"BMC Infect Dis"},{"key":"5540_CR117","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","volume":"50","author":"GL Sacha","year":"2022","unstructured":"Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR. Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock. Crit Care Med. 2022;50:614\u201323.","journal-title":"Crit Care Med"},{"key":"5540_CR118","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.chest.2023.07.009","volume":"164","author":"GL Sacha","year":"2023","unstructured":"Sacha GL, Bauer SR. Optimizing vasopressin use and initiation timing in septic shock: A narrative review. Chest. 2023;164:1216\u201327.","journal-title":"Chest"},{"key":"5540_CR119","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/08850666231201364","volume":"39","author":"D Ragoonanan","year":"2024","unstructured":"Ragoonanan D, Nickelsen P, Tran N, Allen B, Emborski R, Legare A, et al. Vasopressin initiation as a Second-Line vasopressor in early septic shock (VISPSS). J Intensive Care Med. 2024;39:306\u201312.","journal-title":"J Intensive Care Med"},{"key":"5540_CR120","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13613-018-0379-5","volume":"8","author":"GL Sacha","year":"2018","unstructured":"Sacha GL, Lam SW, Duggal A, Torbic H, Bass SN, Welch SC, et al. Predictors of response to fixed-dose vasopressin in adult patients with septic shock. Ann Intensive Care. 2018;8:35.","journal-title":"Ann Intensive Care"},{"key":"5540_CR121","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13613-025-01472-w","volume":"15","author":"M Melchers","year":"2025","unstructured":"Melchers M, de Smet V, Rooijakkers C, Huising J, Vermeulen W, K\u00f6kta\u015f BNN, et al. Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study. Ann Intensive Care. 2025;15:59.","journal-title":"Ann Intensive Care"},{"key":"5540_CR122","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/SHK.0000000000001978","volume":"58","author":"AC Rydz","year":"2022","unstructured":"Rydz AC, Elefritz JL, Conroy M, Disney KA, Miller CJ, Porter K, et al. EARLY INITIATION OF VASOPRESSIN REDUCES ORGAN FAILURE AND MORTALITY IN SEPTIC SHOCK. Shock Augusta Ga. 2022;58:269\u201374.","journal-title":"Shock Augusta Ga"},{"key":"5540_CR123","first-page":"295","volume":"26","author":"KC White","year":"2024","unstructured":"White KC, Costa-Pinto R, Chaba A, McIlroy P, Senthuran S, Luke S, et al. Timing of adjunctive vasopressin initiation for septic shock patients and hospital mortality: A multicentre observational study. Crit Care Resusc J Australas Acad Crit Care Med. 2024;26:295\u2013302.","journal-title":"Crit Care Resusc J Australas Acad Crit Care Med"},{"key":"5540_CR124","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ajem.2023.04.040","volume":"69","author":"D He","year":"2023","unstructured":"He D, Zhang L, Hu H, Gu W-J, Lu X, Qiu M, et al. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database. Am J Emerg Med. 2023;69:188\u201394.","journal-title":"Am J Emerg Med"},{"key":"5540_CR125","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/10600280221118903","volume":"57","author":"AL Brask","year":"2023","unstructured":"Brask AL, Shemanski SM, Barnes TE, Holmes AK. Timing of vasopressin addition to norepinephrine and efficacy outcomes in patients with septic shock. Ann Pharmacother. 2023;57:521\u20136.","journal-title":"Ann Pharmacother"},{"key":"5540_CR126","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/phar.2105","volume":"38","author":"DA Hammond","year":"2018","unstructured":"Hammond DA, Ficek OA, Painter JT, McCain K, Cullen J, Brotherton AL, et al. Prospective Open-label trial of early concomitant vasopressin and norepinephrine therapy versus initial norepinephrine monotherapy in septic shock. Pharmacotherapy. 2018;38:531\u20138.","journal-title":"Pharmacotherapy"},{"key":"5540_CR127","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1177\/0885066617725255","volume":"34","author":"DA Hammond","year":"2019","unstructured":"Hammond DA, Cullen J, Painter JT, McCain K, Clem OA, Brotherton AL, et al. Efficacy and safety of the early addition of vasopressin to norepinephrine in septic shock. J Intensive Care Med. 2019;34:910\u20136.","journal-title":"J Intensive Care Med"},{"key":"5540_CR128","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/10600280221095543","volume":"58","author":"MM McCloskey","year":"2024","unstructured":"McCloskey MM, Gibson GA, Pope HE, Giacomino BD, Hampton N, Micek ST, et al. Effect of early administration of vasopressin on New-Onset arrhythmia development in patients with septic shock: A retrospective, observational cohort study. Ann Pharmacother. 2024;58:5\u201314.","journal-title":"Ann Pharmacother"},{"key":"5540_CR129","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jcrc.2014.03.005","volume":"29","author":"DP Reardon","year":"2014","unstructured":"Reardon DP, DeGrado JR, Anger KE, Szumita PM. Early vasopressin reduces incidence of new onset arrhythmias. J Crit Care. 2014;29:482\u20135.","journal-title":"J Crit Care"},{"key":"5540_CR130","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/SHK.0000000000002214","volume":"60","author":"E Ye","year":"2023","unstructured":"Ye E, Ye H, Wang S, Fang X, INITIATION TIMING OF VASOPRESSOR. IN PATIENTS WITH SEPTIC SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS. Shock Augusta Ga. 2023;60:627\u201336.","journal-title":"Shock Augusta Ga"},{"key":"5540_CR131","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13613-025-01428-0","volume":"15","author":"C-H Ma","year":"2025","unstructured":"Ma C-H, Healy J, Kinteh E, Ma C-C, Tzeng C-FT, Chou EH, et al. Extremely early initiation of vasopressors might not decrease short-term mortality for adults with septic shock: a systematic review and meta-analysis. Ann Intensive Care. 2025;15:18.","journal-title":"Ann Intensive Care"},{"key":"5540_CR132","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13054-025-05401-y","volume":"29","author":"KC White","year":"2025","unstructured":"White KC, Costa-Pinto R, Blank S, Whebell S, Quick L, Luke S, et al. Effect of early adjunctive vasopressin initiation for septic shock patients: a target trial emulation. Crit Care Lond Engl. 2025;29:188.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR133","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13054-023-04500-y","volume":"27","author":"B Garcia","year":"2023","unstructured":"Garcia B, Legrand M. Adjunctive vasopressors in distributive shock: how soon is early? Crit Care. 2023;27:210.","journal-title":"Crit Care"},{"key":"5540_CR134","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13613-022-01021-9","volume":"12","author":"MA Ammar","year":"2022","unstructured":"Ammar MA, Ammar AA, Wieruszewski PM, Bissell BD, Long T, Albert M. Timing of vasoactive agents and corticosteroid initiation in septic shock. Ann Intensive Care. 2022;12:47.","journal-title":"Ann Intensive Care"},{"key":"5540_CR135","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.chest.2022.09.019","volume":"163","author":"B Teja","year":"2023","unstructured":"Teja B, Bosch NA, Walkey AJ. How we escalate vasopressor and corticosteroid therapy in patients with septic shock. Chest. 2023;163:567\u201374.","journal-title":"Chest"},{"key":"5540_CR136","doi-asserted-by":"crossref","unstructured":"Kalimouttou A, Kennedy JN, Feng J, Singh H, Saria S, Angus DC et al. Optimal vasopressin initiation in septic shock: the OVISS reinforcement learning study. JAMA. 2025;e253046.","DOI":"10.1001\/jama.2025.3046"},{"key":"5540_CR137","first-page":"e0634","volume":"4","author":"SR Bauer","year":"2022","unstructured":"Bauer SR, Sacha GL, Siuba MT, Lam SW, Reddy AJ, Duggal A, et al. Association of arterial pH with hemodynamic response to vasopressin in patients with septic shock: an observational cohort study. Crit Care Explor. 2022;4:e0634.","journal-title":"Crit Care Explor"},{"key":"5540_CR138","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1097\/CCM.0000000000002323","volume":"45","author":"JA Russell","year":"2017","unstructured":"Russell JA, Lee T, Singer J, Boyd JH, Walley KR. Vasopressin and septic shock trial (VASST) group. The septic shock 3.0 definition and trials: A vasopressin and septic shock trial experience. Crit Care Med. 2017;45:940\u20138.","journal-title":"Crit Care Med"},{"key":"5540_CR139","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13054-023-04583-7","volume":"27","author":"K Nakamura","year":"2023","unstructured":"Nakamura K, Nakano H, Ikechi D, Mochizuki M, Takahashi Y, Koyama Y, et al. The vasopressin loading for refractory septic shock (VALOR) study: a prospective observational study. Crit Care Lond Engl. 2023;27:294.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR140","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/SHK.0000000000001345","volume":"53","author":"Z Wu","year":"2020","unstructured":"Wu Z, Zhang S, Xu J, Xie J, Huang L, Huang Y, et al. Norepinephrine vs vasopressin: which vasopressor should be discontinued first in septic shock?? A Meta-Analysis. Shock Augusta Ga. 2020;53:50\u20137.","journal-title":"Shock Augusta Ga"},{"key":"5540_CR141","doi-asserted-by":"crossref","unstructured":"Mallmann C, Galiotto TMB, de Oliveira MS, Moraes RB. Reduction of norepinephrine versus vasopressin in the stabilization phase of septic shock: RENOVA clinical trial. Med Intensiva. 2025;502147.","DOI":"10.1016\/j.medine.2025.502147"},{"key":"5540_CR142","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/01.shk.0000235140.97903.90","volume":"27","author":"C Ertmer","year":"2007","unstructured":"Ertmer C, Bone H-G, Morelli A, Van Aken H, Erren M, Lange M, et al. METHYLPREDNISOLONE REVERSES VASOPRESSIN HYPORESPONSIVENESS IN OVINE ENDOTOXEMIA. Shock. 2007;27:281.","journal-title":"Shock"},{"key":"5540_CR143","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","volume":"42","author":"AC Gordon","year":"2014","unstructured":"Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med. 2014;42:1325\u201333.","journal-title":"Crit Care Med"},{"key":"5540_CR144","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1097\/CCM.0000000000000262","volume":"42","author":"P Asfar","year":"2014","unstructured":"Asfar P, Tuckermann J, Radermacher P. Steroids and vasopressin in septic shock-brother and sister or just distant cousins? Crit Care Med. 2014;42:1531\u20132.","journal-title":"Crit Care Med"},{"key":"5540_CR145","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","volume":"37","author":"JA Russell","year":"2009","unstructured":"Russell JA, Walley KR, Gordon AC, Cooper DJ, H\u00e9bert PC, Singer J, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med. 2009;37:811\u20138.","journal-title":"Crit Care Med"},{"key":"5540_CR146","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/10600280231191131","volume":"58","author":"AM Alshehri","year":"2024","unstructured":"Alshehri AM, Kovacevic MP, Dube KM, Lupi KE, DeGrado JR. Comparison of early versus late adjunctive vasopressin and corticosteroids in patients with septic shock. Ann Pharmacother. 2024;58:461\u20138.","journal-title":"Ann Pharmacother"},{"key":"5540_CR147","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1164\/rccm.201302-0355OC","volume":"188","author":"JA Russell","year":"2013","unstructured":"Russell JA, Fjell C, Hsu JL, Lee T, Boyd J, Thair S, et al. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. Am J Respir Crit Care Med. 2013;188:356\u201364.","journal-title":"Am J Respir Crit Care Med"},{"key":"5540_CR148","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00134-022-06905-9","volume":"49","author":"C Cleasby","year":"2023","unstructured":"Cleasby C, Marshall T, Gordon AC, Antcliffe DB. The effect of vasopressin and hydrocortisone on cytokine trajectories. Intensive Care Med. 2023;49:241\u20133.","journal-title":"Intensive Care Med"},{"key":"5540_CR149","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","volume":"199","author":"DB Antcliffe","year":"2019","unstructured":"Antcliffe DB, Burnham KL, Al-Beidh F, Santhakumaran S, Brett SJ, Hinds CJ, et al. Transcriptomic signatures in Sepsis and a differential response to steroids. From the VANISH randomized trial. Am J Respir Crit Care Med. 2019;199:980\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"5540_CR150","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"*","year":"2018","unstructured":"*. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378:809\u201318.","journal-title":"N Engl J Med"},{"key":"5540_CR151","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378:797\u2013808.","journal-title":"N Engl J Med"},{"key":"5540_CR152","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377:419\u201330.","journal-title":"N Engl J Med"},{"key":"5540_CR153","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","volume":"27","author":"PM Wieruszewski","year":"2023","unstructured":"Wieruszewski PM, Bellomo R, Busse LW, Ham KR, Zarbock A, Khanna AK, et al. Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial. Crit Care. 2023;27:175.","journal-title":"Crit Care"},{"key":"5540_CR154","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","volume":"159","author":"PM Wieruszewski","year":"2021","unstructured":"Wieruszewski PM, Wittwer ED, Kashani KB, Brown DR, Butler SO, Clark AM, et al. Angiotensin II infusion for shock: A multicenter study of postmarketing use. Chest. 2021;159:596\u2013605.","journal-title":"Chest"},{"key":"5540_CR155","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13054-024-05212-7","volume":"28","author":"Y Kotani","year":"2024","unstructured":"Kotani Y, Belletti A, D\u2019Amico F, Bonaccorso A, Wieruszewski PM, Fujii T, et al. Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials. Crit Care Lond Engl. 2024;28:439.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR156","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13063-024-07995-0","volume":"25","author":"JP Teixeira","year":"2024","unstructured":"Teixeira JP, Perez Ingles D, Barton JB, Dean JT, Garcia P, Kunkel SJ, et al. The scientific rationale and study protocol for the DPP3, angiotensin II, and Renin kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock. Trials. 2024;25:182.","journal-title":"Trials"},{"key":"5540_CR157","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","volume":"26","author":"PM Wieruszewski","year":"2022","unstructured":"Wieruszewski PM, Khanna AK. Vasopressor choice and timing in vasodilatory shock. Crit Care Lond Engl. 2022;26:76.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR158","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/cc7990","volume":"13","author":"A Morelli","year":"2009","unstructured":"Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13:R130.","journal-title":"Crit Care"},{"key":"5540_CR159","first-page":"1043","volume":"59","author":"P Svoboda","year":"2012","unstructured":"Svoboda P, Scheer P, Kantorov\u00e1 I, Doubek J, Dudra J, Radvan M, et al. Terlipressin in the treatment of late phase catecholamine-resistant septic shock. Hepatogastroenterology. 2012;59:1043\u20137.","journal-title":"Hepatogastroenterology"},{"key":"5540_CR160","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/bja\/aen017","volume":"100","author":"A Morelli","year":"2008","unstructured":"Morelli A, Ertmer C, Lange M, D\u00fcnser M, Rehberg S, Van Aken H, et al. Effects of short-term simultaneous infusion of Dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth. 2008;100:494\u2013503.","journal-title":"Br J Anaesth"},{"key":"5540_CR161","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","volume":"44","author":"Z-M Liu","year":"2018","unstructured":"Liu Z-M, Chen J, Kou Q, Lin Q, Huang X, Tang Z, et al. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med. 2018;44:1816\u201325.","journal-title":"Intensive Care Med"},{"key":"5540_CR162","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12871-020-00965-4","volume":"20","author":"L Huang","year":"2020","unstructured":"Huang L, Zhang S, Chang W, Xia F, Liu S, Yang Y, et al. Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis. BMC Anesthesiol. 2020;20:58.","journal-title":"BMC Anesthesiol"},{"key":"5540_CR163","doi-asserted-by":"publisher","first-page":"155038","DOI":"10.1016\/j.jcrc.2025.155038","volume":"87","author":"J Skvarce","year":"2025","unstructured":"Skvarce J, Bui A, Oro P, Sachar S, Harnegie MP, Kapoor A, et al. Multisystem hemodynamic effects of terlipressin in cirrhosis: A scoping review. J Crit Care. 2025;87:155038.","journal-title":"J Crit Care"},{"key":"5540_CR164","first-page":"552","volume":"37","author":"A Choudhury","year":"2017","unstructured":"Choudhury A, Kedarisetty CK, Vashishtha C, Saini D, Kumar S, Maiwall R, et al. A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock. Liver Int Off J Int Assoc Study Liver. 2017;37:552\u201361.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"5540_CR165","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13054-017-1798-7","volume":"21","author":"JA Russell","year":"2017","unstructured":"Russell JA, Vincent J-L, Kj\u00f8lbye AL, Olsson H, Blemings A, Spapen H, et al. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. Crit Care Lond Engl. 2017;21:213.","journal-title":"Crit Care Lond Engl"},{"key":"5540_CR166","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1001\/jama.2019.14607","volume":"322","author":"P-F Laterre","year":"2019","unstructured":"Laterre P-F, Berry SM, Blemings A, Carlsen JE, Fran\u00e7ois B, Graves T, et al. Effect of selepressin vs placebo on Ventilator- and Vasopressor-Free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial. JAMA. 2019;322:1476\u201385.","journal-title":"JAMA"},{"key":"5540_CR167","doi-asserted-by":"publisher","first-page":"P158","DOI":"10.1186\/cc13348","volume":"18","author":"S Oliveira","year":"2014","unstructured":"Oliveira S, Dessa F, Rocha C, Oliveira F. Early vasopressin application in shock study. Crit Care. 2014;18:P158.","journal-title":"Crit Care"},{"key":"5540_CR168","first-page":"578","volume":"21","author":"E Barzegar","year":"2017","unstructured":"Barzegar E, Nouri M, Mousavi S, Ahmadi A, Mojtahedzadeh M. Vasopressin in septic shock; assessment of Sepsis biomarkers: A randomized, controlled trial. Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med. 2017;21:578\u201384.","journal-title":"Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med"},{"key":"5540_CR169","unstructured":"Intermountain Health Care, Inc. Vasopressin for Septic Shock Pragmatic Trial (VASSPR) [Internet]. clinicaltrials.gov; 2024 Feb. Report No.: NCT06217562. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06217562"},{"key":"5540_CR170","doi-asserted-by":"publisher","first-page":"e0304227","DOI":"10.1371\/journal.pone.0304227","volume":"19","author":"R McDonald","year":"2024","unstructured":"McDonald R, Watchorn J, Mehta R, Ostermann M, Hutchings S. The REPERFUSE study protocol: the effects of vasopressor therapy on renal perfusion in patients with septic shock-A mechanistically focused randomised control trial. PLoS ONE. 2024;19:e0304227.","journal-title":"PLoS ONE"},{"key":"5540_CR171","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/01.CCM.0000178182.37639.D6","volume":"33","author":"J Alban\u00e8se","year":"2005","unstructured":"Alban\u00e8se J, Leone M, Delmas A, Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med. 2005;33:1897\u2013902.","journal-title":"Crit Care Med"},{"key":"5540_CR172","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/0886022X.2022.2095286","volume":"44","author":"J Wang","year":"2022","unstructured":"Wang J, Shi M, Huang L, Li Q, Meng S, Xu J, et al. Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study. Ren Fail. 2022;44:1207\u201315.","journal-title":"Ren Fail"},{"key":"5540_CR173","first-page":"669","volume":"26","author":"P Sahoo","year":"2022","unstructured":"Sahoo P, Kothari N, Goyal S, Sharma A, Bhatia PK. Comparison of norepinephrine and terlipressin vs norepinephrine alone for management of septic shock: A randomized control study. Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med. 2022;26:669\u201375.","journal-title":"Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05540-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:11:54Z","timestamp":1757315514000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05540-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":173,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5540"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05540-2","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"333"}}